Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paroxetine hydrochloride hemihydrate, quantity: 22.2 mg (equivalent: paroxetine, qty 20 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; calcium hydrogen phosphate dihydrate; sodium starch glycollate type a; magnesium stearate; calcium hydrogen phosphate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400 - for the treatment of:,? major depression and for the prevention of relapse of depressive symptoms;,? obsessive compulsive disorder and for the prevention of relapse of ocd;,? panic disorder and for the prevention of relapse of panic disorder;,? social anxiety disorder/social phobia; and,? generalised anxiety disorder;,? posttraumatic stress disorder.

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

rosemont pharmaceuticals ltd - cimetidine - oral solution - 40mg/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - cimetidine - solution for injection - 100mg/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - cimetidine - effervescent tablet - 400mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

accura health ltd - cimetidine - oral tablet - 100mg

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - doxepin hydrochloride, quantity: 11.3 mg (equivalent: doxepin, qty 10 mg) - capsule, hard - excipient ingredients: purified talc; lactose monohydrate; sodium starch glycollate; magnesium stearate; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; sorbitan monolaurate; potable water; gelatin; sodium laureth sulfate - for the treatment of major depression.

Saudi - Kiingereza - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

smiithkline beecham - cimetidine - tablet - 400 mg

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paroxetine hydrochloride, quantity: 22.22 mg (equivalent: paroxetine, qty 20 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; magnesium stearate; microcrystalline cellulose; mannitol; basic butylated methacrylate copolymer; titanium dioxide; purified talc; polyvinyl alcohol; sodium lauryl sulfate; glyceryl monostearate - treatment of major depression and for the prevention of relapse of depressive symptoms; treatment of obsessive compulsive disorder and for the prevention of relapse of ocd; treatment of panic disorder and for the prevention of relapse of panic disorder; treatment of social anxiety disorder/ social phobia; treatment of generalised anxiety disorder; and treatment of post-traumatic stress disorder

Afrika Kusini - Kiingereza - South African Health Products Regulatory Authority (SAHPRA)

pharmacare limited û woodmead - tablet - see ingredients - each tablet contains cimetidine 200 mg

Afrika Kusini - Kiingereza - South African Health Products Regulatory Authority (SAHPRA)

pharmacare limited û woodmead - syrup - see ingredients - each 5 ml syrup contains cimetidine hydrochloride equivalent to cimetidine 200 mg